The FDA has granted Dune Medical Devices premarket approval for its MarginProbe System, which is targeted for immediate U.S. distribution. The device, which has been marketed since 2008 in Europe, is used to aid in the detection of additional tumor cells in women undergoing breast cancer procedures and is intended to decrease the need for further surgeries.
FDA approves breast cancer device from Dune Medical
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan